June 1, 1983

A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma

JRJoseph RubinMayo Clinic in Arizona SSScot SorensenPrairie View A&M University ASAllan J. SchuttMayo Clinic

Key Points

Key points are not available for this paper at this time.

Abstract

Rubin, Joseph M.D.; Sorensen, Scot M.D.; Schutt, Allan J. M.D.; van Hazel, Guy A. M.B.; O'Connell, Michael J. M.D.; Moertel, Charles G. M.D. Author Information

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Rubin et al. (Wed,) studied this question.

synapsesocial.com/papers/6a346ae53ff9d4fd57cfa797 https://doi.org/https://doi.org/10.1097/00000421-198306000-00012

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper